Literature DB >> 21777369

The dual thromboxane receptor antagonist and thromboxane synthase inhibitor EV-077 is a more potent inhibitor of platelet function than aspirin.

P Fontana, P Alberts, K S Sakariassen, H Bounameaux, J-P Meyer, A Santana Sorensen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21777369     DOI： 10.1111/j.1538-7836.2011.04446.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  8 in total

1.  Pharmacodynamic effects of EV-077: results of an in vitro pilot investigation in healthy volunteers.

Authors:  Antonio Tello-Montoliu; Fabiana Rollini; Bhaloo Desai; Giuseppe Pasqualino; Ronakkumar Patel; Alexandra Santana Sorensen; Kjell S Sakariassen; Dominick J Angiolillo
Journal:  J Thromb Thrombolysis       Date:  2012-10       Impact factor: 2.300

2.  Single ascending oral dose pharmacokinetics and pharmacodynamics study of EV-077: the specific inhibitor of prostanoid- and isoprostane-induced cellular activation.

Authors:  A Richardson; K S Sakariassen; J-P Meyer; P Alberts; A S Sorensen
Journal:  Eur J Clin Pharmacol       Date:  2012-07-20       Impact factor: 2.953

Review 3.  Antiplatelet therapy: targeting the TxA2 pathway.

Authors:  P Fontana; A Zufferey; Y Daali; J-L Reny
Journal:  J Cardiovasc Transl Res       Date:  2013-12-19       Impact factor: 4.132

Review 4.  Platelet function profiles in patients with diabetes mellitus.

Authors:  Fabiana Rollini; Francesco Franchi; Ana Muñiz-Lozano; Dominick J Angiolillo
Journal:  J Cardiovasc Transl Res       Date:  2013-02-13       Impact factor: 4.132

5.  Pharmacodynamic effects of EV-077 in patients with diabetes mellitus and coronary artery disease on aspirin or clopidogrel monotherapy: results of an in vitro pilot investigation.

Authors:  Fabiana Rollini; Antonio Tello-Montoliu; Ronakkumar Patel; Andrew Darlington; Ryan E Wilson; Francesco Franchi; Ana Muñiz-Lozano; Bhaloo Desai; Norbert Bender; Kjell S Sakariassen; Dominick J Angiolillo
Journal:  J Thromb Thrombolysis       Date:  2014       Impact factor: 2.300

6.  Licochalcones extracted from Glycyrrhiza inflata inhibit platelet aggregation accompanied by inhibition of COX-1 activity.

Authors:  Asa Okuda-Tanino; Daiki Sugawara; Takumi Tashiro; Masaya Iwashita; Yutaro Obara; Takahiro Moriya; Chisato Tsushima; Daisuke Saigusa; Yoshihisa Tomioka; Kuniaki Ishii; Norimichi Nakahata
Journal:  PLoS One       Date:  2017-03-10       Impact factor: 3.240

7.  Inverse agonism of SQ 29,548 and Ramatroban on Thromboxane A2 receptor.

Authors:  Raja Chakraborty; Rajinder P Bhullar; Shyamala Dakshinamurti; John Hwa; Prashen Chelikani
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

8.  Prostacyclin, thromboxane and glomerular filtration rate are abnormal in sickle cell pregnancy.

Authors:  Opeyemi Abayomi Obilade; Alani Suleimon Akanmu; Fiona Broughton Pipkin; Bosede Bukola Afolabi
Journal:  PLoS One       Date:  2017-09-07       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.